baber/WOPTO huggingface dataset:
Patent NZ-529610-A (NZ)
Title: Overhead garage door with hinge arrangement to avoid pinching of fingers
Inventor: WRIGHT KEVIN E
IPC: E06B3/48
Filed: 2001-12-07
Abstract: The present invention relates to a pinch-proof garage door for protecting human fingers from being pinched. The garage door includes a plurality of horizontally aligned garage door panels. Each garage door panel has a male portion (40) and a female portion (39), wherein the male and female portions cooperate with each other in such a manner so as to minimize a gap therebetween. Each garage door panel is removably connected together by a hinge assembly which cooperates with the garage door panels so as to prevent human fingers from being pinched by the inside of the garage door.
Patent NZ-531379-A (NZ)
Title: Methods, systems and computer program products for serialising and deserialising data objects of various types
Inventor: PHARIES STEFAN H
IPC: G06F40/00
Filed: 2004-02-25
Abstract: Methods for converting a computing system object of one type to an object of another type that allow for the runtime operation of the conversion process to be altered or customized are disclosed. The conversion may occur within an extensible serialization engine that serializes, deserializes, and transforms objects of various types. The runtime operation of the serialization engine is altered by one or more extension routines that implement the desired customizations or extensions, without requiring replacement of other existing routines. Based on type information, identified for an initial object, the object is converted to an intermediate representation which permits runtime modification, including modification of object names, object types, and object data. The intermediate representation of the initial object is modified in accordance with extension routines that alter the runtime operation of the serialization engine, and the intermediate representation is converted to a final object and type.
Patent NZ-531405-A (NZ)
Title: Plaster for the treatment of dysfunctions and disorders of nails
Inventor: SUSILO RUDY
IPC: A61K8/02
Filed: 2002-09-04
Abstract: A plaster for prophylaxis and/or treatment of dysfunctions or disorders of nails, especially onychomycosis, onychocryptosis, nail psoriasis, melanonychia striata, and onychodystrophy, the use of the plaster and methods for prophylaxis and/or treatment of a dysfunction or disorder of nails using the plaster is disclosed, wherein the plaster comprises: a contact layer designed to be in close contact with the nail and optionally with the surrounding skin; said layer comprising: (a) an adhesive; (b) at least one skin and/or nail permeation enhancer; and (c) at least one additive selected from the group comprising binders, cross linkers, softeners, solvents, fillers, antioxidants and mixtures thereof, wherein on antifungal agent is present in the plaster. The said dysfunction or disorder of nails may be induced or caused by drugs, systemic diseases, chemical compounds, physical influences, fungal, yeast, or bacterial infection of the nails and/or the nail beds, or in the context of skin diseases. The plaster shows good therapeutically effects on said dysfunction or disorder of nails without the need of drilling a hole into the nail and/or daily scraping of the nail. A preferred embodiment of the plaster consists of an occlusive backing layer and a contact layer attached to said backing layer, wherein the contact layer comes in close contact with the nail and optionally with the surrounding skin, and wherein the contact layer is made of an adhesive, a skin and/or nail permeation enhancer, and suitable additives.
Patent NZ-535952-A (NZ)
Title: Immunostimulatory G,U-containing oligoribonucleotides
Inventor: LIPFORD GRAYSON B
IPC: A61K31/205
Filed: 2003-04-04
Abstract: Disclosed is an immunostimulatory composition, comprising: an isolated RNA oligomer 5-40 nucleotides long having a base sequence comprising at least one guanine (G) and at least one uracil (D), wherein the base sequence: (a) comprises 5'-RDRGY-3', wherein R represents purine, U represents uracil, G represents guanine, and Y represents pyrimidine; (b) comprises 5'-GDAGD 3', wherein A represents adenine; (c) comprises 5'-GDAGDGU-3'; (d) comprises 5'-GDDGB-3', wherein B represents D, G, or C, wherein C represents cytosine; (e) comprises 5'-GDGUG-3'; (f) comprises 5'-GDGUUUAC-3'; (g) comprises 5'-GUAGGCAC-3'; (h) comprises 5'-CDAGGCAC-3'; (i) comprises 5-CUCGGCAC-3'; (j) is free of CpG dinucleotide; (k) is at least 50 percent self- complementary; or (I) is a G, U-rich RNA, and any combination thereof; and further comprising an antigen. Also disclosed are uses of said composition in the manufacture of medicaments.
Patent NZ-536931-A (NZ)
Title: A data editor
Inventor: SEGAR ANDREW PAUL
IPC: G06F19/00
Filed: 2004-12-01
Abstract: A data or relationship editor computer program has instructions that when the editor is running, the editor presents a series of data nodes on a display. The nodes can be selected to enable the editing of data corresponding to each node without the user having to open a widow, panel or frame to access such data or the user having to go to a separate window, panel or frame and open a file to access such data.
Patent NZ-538405-A (NZ)
Title: Improved treatment of cancer with glutamine and carbohydrate
Inventor: KLIMBERG V SUZANNE
IPC: A61K47/26
Filed: 2003-07-31
Abstract: Disclosed is the use of (a) glutamine or a pharmaceutically acceptable salt thereof, and (b) carbohydrate, in an amount effective to increase the absorption of glutamine by a mammalian subject afflicted with cancer, in remission from cancer or undergoing anti-cancer therapy, or at risk of developing cancer, in the manufacture of medicaments for preventing metastasis, preventing recurrence of cancer, inhibiting the onset of cancer, protecting non-mucosal tissue against damage from the radiation therapy, protecting skin against damage from the chemotherapy, protecting breast tissue against damage from the chemotherapy, reducing or preventing pain in a non-mucosal tissue arising from treatment with chemotherapy and/or radiation, enhancing the effectiveness of chemotherapy and/or radiation therapy, promoting apoptosis of cancer cells or enhancing natural killer cell activity in said subject, wherein the medicament is formulated for separate, sequential or simultaneous administration of (a) and (b).
Patent NZ-540471-A (NZ)
Title: A method for improving protein production
Inventor: OTTE ARIE PIETER
IPC: C12Q1/68
Filed: 2003-12-02
Abstract: Disclosed is a method for the production of proteins in a (host) cell. The method uses a TRAnscription Pause (TRAP) sequence to enhance a protein expression characteristic of a protein expression unit. The TRAP sequence is thought to at least in part prevent formation of antisense RNA or to at least in part prevent transcription to enter said protein expression unit. In one embodiment, disclosed is a method for expression of at least one protein of interest in a cell comprising providing said cell with at least one protein expression unit which unit comprises a promoter functionally linked to an open reading frame. The open reading frame encodes at least one protein of interest, characterised in that said protein expression unit further comprises at least one TRAnscription Pause (TRAP) sequence. Wherein said TRAP sequence is functionally located downstream of said open reading frame and at least in part prevents formation of antisense RNA. In yet another embodiment said TRAP sequence is functionally located upstream of said promoter and at least in part prevents transcription to enter said expression unit. Additionally the expression protein unit further comprises at least one STabilizing Anti-Repressor (STAR) sequence.
Patent NZ-540612-A (NZ)
Title: 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
Inventor: JONES ROBERT M
IPC: C07D417/14
Filed: 2004-01-14
Abstract: Disclosed are compounds of formula (Ia) wherein: A and B are independently alkylene optionally substituted with methyl groups; D is CR2R3; V is absent; W is NR4, O or S; X is N or CR5; Y is N or CR6; and the remaining substituents are as defined in the specification. Compounds of the type disclosed modulate the activity of the GPCR known as RUP3 and are useful as modulators of the metabolism, and in treating obesity and diabetes.
Patent NZ-542311-A (NZ)
Title: A single use laryngoscope
Inventor: YEE KEVIN FINEHING
IPC: A61B1/267
Filed: 2004-02-11
Abstract: A laryngoscope (10) to assist tracheal intubation on a patient, comprising a body having a handle (14), and a laryngoscope blade (12) extending from the handle; a lighting system (21) including a light source integrated in the laryngoscope body and arranged in use to be activated to adopt an operational mode to provide illumination to the patient's throat; control means operative to allow only a single occurrence of the lighting system in the operational mode; and wherein once activated in the operational mode, the lighting system provides illumination for only a limited time.
Patent NZ-550178-A (NZ)
Title: Modular intervertebral implant or intervertebral disc prosthesis
Inventor: STUDER ARMIN
IPC: A61F2/00
Filed: 2004-04-02
Abstract: Middle piece for a modular intervertebral implant or a modular disk prosthesis, having means for the detachable attachment to an apposition plate 3 5 suitable for the apposition at the base plate or covering plate of a body of a vertebra, wherein: A) the middle piece has a longitudinal axis, is elastic parallel to the latter and has a progressive spring performance curve f; and B) the spring performance curve f has a spring rate of between 450 N/mm and 550 N/mm in a first partial region and a spring rate of between 1400 N/mm and 1600 N/mm in a second partial region.
Patent NZ-552042-A (NZ)
Title: Cladding system
Inventor: GRANT MATTHEW BRUCE
Filed: 2006-12-12
Abstract: A cladding support bracket (4) for positioning and supporting a cladding element (10a) for attachment to a building structure. The bracket has a first support member (9) adapted to receive a lower edge of a cladding element (10a) and an attachment member (5) adapted to be attached to the building structure. The first support member is coupled for the attachment member and extends from the attachment member at an angle to the attachment member. The bracket further includes a second support member (21) adapted to support a cavity spacer (22).
Patent NZ-552288-A (NZ)
Title: Stratified cementitious composite
Inventor: BELLAMY LARRY ARTHUR
Filed: 2006-12-20
Abstract: Disclosed is a method for forming a stratified cementitious body comprising placing into a mould a cementitious slurry comprising a cementitious binder, to form the body in a single pour and curing the slurry to form a stratified cementitious body, the slurry having a yield shear stress of less than about 300 Pa and a plastic viscosity of less than about 70 Pa.s.. Also disclosed is a method of forming a stratified cementitious body comprising the steps of: (i) mixing a cementitious binder and at least one aggregate material with water to form a slurry, the slurry having a yield shear stress of less than about 300 Pa and a plastic viscosity of less than about 70 Pa.s., (ii) pouring the slurry into a mould in a single pour, (iii) allowing the slurry to stratify into layers under the influence of gravitational forces and/or buoyancy forces, (iv) optionally applying vibrations to the slurry to encourage the slurry to stratify into layers, and (v) curing the slurry to form a stratified cementitious body.
Patent NZ-554828-A (NZ)
Title: Medicine injection devices and methods
Inventor: WYRICK RONALD E
IPC: A61M5/20
Filed: 2004-12-06
Abstract: A reloadable medicine injector 30 includes a barrel tube 31 with a receiving cavity slidingly housing a syringe subassembly 10 and a muzzle end 32 with a needle receiving aperture 34. A trigger mechanism 36 can be activated to move the syringe subassembly forward so as to inject the syringe needle. A penetration control element 38, 39 controls the injection needle penetration depth, and is a separate piece from the tube, is entirely contained within the tube, and surrounds the needle when the needle is in the retracted position within the tube. In one form the penetration control element is a rigid sleeve 38 against which the syringe assembly is stopped in its forward motion. In another form the penetration control element is the front return coil spring that is provided with at least two dead windings that lie directly adjacent to one another.
Patent NZ-561604-A (NZ)
Title: Areal metal element and profile element
Inventor: KRETTENAUER KILIAN
Filed: 2003-11-25
Abstract: A longitudinal areal metal element has a surface which extends, perpendicular to the longitudinal direction, from a first outside edge 8 to a second outside edge 9 lying opposite the first outside edge, with the region of the metal element adjoining the first outside edge forming a first side region 14 and the region of the metal element adjoining the second outer edge forming a second side region 15. The side regions are connected to one another by a central region lying between them, and with a plurality of completely bordered apertures 22 being consecutively arranged in the longitudinal direction of the metal element and being formed in the side regions, with its border in each case being formed in one part by said side region and in the other part by the central region. The central region includes a plurality of sections which each consist of two outwardly disposed part sections 31, 33 and a central part section 32 lying between them, with the outwardly disposed part sections being folded over with respect to the central part section for the production of the aperture; with the sections forming part of the borders of the apertures; and with the central region, including the sections, being made in one piece with the two side regions of the metal element. A plurality of folding edges 16, 17 18, 19 are provided which are formed by the folding over of the outwardly disposed sections 31, 33, with respect to the central part section 32 and of which the folding edges 17, 19 disposed more closely to the first outer edge 8 of the metal element point in the direction of the first outer edge and the folding edges 16, 18 disposed more closely to the second outer edge 9 of the metal element point in the opposite way thereto in the direction of the second outer edge.
Patent NZ-573513-A (NZ)
Title: Continuous distillation machine comprising a stripping column and a heat exchanger
Inventor: POLIANSKI ALEXANDRE BORISOVICH
IPC: C12H6/02
Filed: 2010-03-02
Abstract: A Continuous Distillation Machine comprises a stripping column and a heat exchanger. The stripping column comprises of four sections 10, 12, 11, 13 one on top of the other, with the first section 10 at the bottom and the fourth section 13 at the top. The first section 10 which is at the lowest end of the column has two separate chambers, a top chamber and a bottom chamber. The bottom chamber connects the disposal outlet of the column's waste reduction to the atmosphere via a breathing elbow on the stripping column's heat exchanger, and the top chamber contains a stainless steel coil which has an opening into the bottom chamber. The coil is surrounded by alcohol containing ferment. Fermented waste passes through the coil and gives up its heat to the surrounding ferment. The alcohol containing ferment is directed into the third section 11. The second section 12 contains packing material that has a high surface area. A heating medium - water and steam is passed through the second section into the third section. Waste is conducted through a coil in the second section 12 to the first section 10. The third section 11 contains plates with holes. Metal tubes pass through the holes and are welded to the plates. The tubes form passages between the bottom and top ends of the third section 11, and are surrounded by boiling ferment from the lower sections. Vapours from the second section 12 travel through the tubes to the fourth packed section 13. The fourth section 13 contains a blind type dephlegmator 2, with an internal coil through which ferment from the heat exchanger 3 flows. Ethanol/water vapours in the dephlegmator 2 gives up heat to the ferment and partially condenses. The heat exchanger 3 comprises five tubular sections forming five main heat exchanging chambers. The two top chambers are an ethanol vapour receiver and an ethanol/ferment heat exchanger. The middle section connects the two halves of the heat exchanger and conducts ethanol to the lower half of the heat exchanger 3. The bottom chamber directs ethanol into a boiler/steam generator 4 and also includes an ethanol trap appendix 17 that is connected to the bottom end of the first section of the stripping column for pressure equalization. ,
Patent NZ-579352-A (NZ)
Title: Oyster farming
Inventor: MAASS-BARRETT TERRENCE JAMES
IPC: A01K21/00
Filed: 2007-03-19
Abstract: A method of identifying larval brood carrying bivalve molluscs is disclosed. The method comprises the steps of: (a) placing one or more bivalve molluscs in contact with a fluid, (b) allowing the or each bivalve mollusc to open sufficiently to enable a device to be (c) placed partially within the opening created and subsequently placing the device (d) partially within the opening of the or at least selected molluscs to maintain or increase the degree of the opening of the mollusc, (e) analysing the or each selected mollusc for the presence of a larval brood, and (f) removing the device. (62) Divided Out of 553944
Patent NZ-582012-A (NZ)
Title: A retractable syringe with an internal needle seal to prevent backflow of undesired fluid
Inventor: THORLEY CRAIG STEPHEN
IPC: A61M5/50
Filed: 2008-07-02
Abstract: Disclosed is a retractable syringe (10), plunger (20) and releasable needle retaining assembly. The releasable needle retaining system comprises a retractable needle (40), a needle seal (43), a retaining member (30) and an ejector member (60) that is operable to release the retractable needle from the retaining member. After delivery of fluid contents of the syringe, the plunger forces the ejector member to release the retractable needle from the retaining member. Decompression of the spring (70) at the end of depression of the plunger facilitates retraction of the retractable needle when engaged with the plunger seal.
Patent NZ-583011-A (NZ)
Title: Device and procedure for the diagnosis or diagnostic preparation and/or therapy monitoring of inflammatory diseases such as rheumatoid arthritis
Inventor: BAHNER MALTE
IPC: A61K49/00
Filed: 2008-08-14
Abstract: Disclosed is a device for a diagnosis and/or therapy monitoring of inflammatory diseases, such as rheumatoid arthritis. It comprises at least a rest or support device (1) for holding at least one extremity (11) of a person. Thereby, the support device has the task of facilitating the at least one extremity, preferably two extremities, for instance the two hands to be comfortably and immovably placed as long as possible. This support device can be provided with a rest with several accessories, such as indentations, bowl-like recesses, ridges, elastic or non-elastic straps and/or loops, etc. At least an excitation source (2) for at least partially illuminating one extremity at least with a radiation of defined excitation wavelength is provided. At least an image sensor (3) is incorporated for capturing at least a reference signal from the extremity as well as several signals from the regions of medical interest (ROI) of the extremity. Moreover, a device according to the invention comprises a comparator for comparing the reference signal with the signals from the regions of medical interest.
Patent NZ-584684-A (NZ)
Title: A method for characterization of a recombinant polyclonal protein
Inventor: FRANSEN TORBEN P
IPC: C07K16/00
Filed: 2008-11-20
Abstract: Disclosed is a method for structural characterisation of a population of different light chain species in a recombinant polyclonal antibody composition, said method comprising the steps of: a.) Manufacturing and purifying a recombinant polyclonal antibody composition; b.) Reducing the cysteine-bridges linking heavy and intact light chains; c.) Separating heavy chains from intact light chains; d.) Subjecting the intact light chains to at least one chromatographic analysis which separates proteins according to physic-chemical properties; e.) Subjecting the separated intact light chains from step (d) to mass spectroscopy; and f.) Analysing data in step (e) to characterise the intact light chain species in the recombinant polyclonal antibody composition. Further disclosed is a method a detecting variance between a population of intact light chains in two or more recombinant polyclonal antibody compositions, comprising performing the above method on each of the compositions and determining any variance between the populations of intact light chains.
Patent NZ-585800-A (NZ)
Title: A fastener for securing rope to a buoy with aligned hook ends for rope and bridging portion that passes through aperture, with fastener rigid and rotated to secure rope to buoy
Inventor: PAYNTER DAVID GRAHAM
IPC: B63B22/04
Filed: 2010-05-31
Abstract: The fastener has two aligned hook portions 7,9 and a bridging portion 11 so as to secure a rope 3 to a buoy 5 having an aperture 6b in a handle 6a. The fastener is rigid.
Patent NZ-589146-A (NZ)
Title: Sporting or amusement apparatus
Inventor: HEASLY CLARE
IPC: A63B24/00
Filed: 2009-05-12
Abstract: Disclosed is a goal assembly (12) including a frame (11) defining the border or mouth of the goal and a height adjustable post formed from a plurality of removable segments (14’). The frame is mountable to one end of the post at a predetermined distance from the ground. A base member (20) supports the post and a power source powers a controller. At least one scoring sensor is mounted proximal the frame (11) and detects passage of a ball past the frame (11) and into the goal. The sensor then provides a signal to the controller and to an electronic scoreboard located on a removable segment (14’) of the post. The score shown on the electronic scoreboard changes automatically in response to information or data transmitted from the scoring sensor(s) to the controller and processed by the controller. A visual display system with one or more light source(s)is then activated by the controller so as to provide a visual display. The visual display incorporates a changing or non-static light pattern on part or all of the frame or the post segments (14’). An audio transmitter is then activated by the controller so as to provide an audio transmission of pre-recorded music programs or themes, or music programs or themes transmitted from an external source.
Patent NZ-589643-A (NZ)
Title: Water cricket game including floating wicket
Inventor: BARNETT MICHAEL
IPC: A63B67/00
Filed: 2009-06-16
Abstract: A kit for a water sport game comprising at least one floatable wicket (20). The wicket includes a frame (22) that is adapted to engage with a plurality of stumps (26). The frame also has an anchor for keeping the wicket within a pre-determined locality in an aquatic environment. The kit also includes a floatable bat comprising a striking blade and a handle located at one end thereof. The blade has a longitudinal axis and the handle is spliced thereto along the longitudinal axis of the blade. The kit also optionally includes at least one floatable ball.
Patent NZ-591261-A (NZ)
Title: Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
Inventor: ILLUM LISBETH
IPC: A61K9/00
Filed: 2009-09-14
Abstract: Provided is the use, in a pharmaceutical composition, of an absorption enhancer comprising polyethylene glycol 660 hydroxy fatty acid ester as an agent for enhancing absorption of a therapeutic agent across a mucosal membrane, wherein the therapeutic agent has a log P value less than about 3 and: (a) is a peptide, protein, nucleic acid, antigen or vaccine; or (b) is not a substrate for P-glycoprotein (P-Gp).